Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Sell
61,675
-30,521
-33% -$48.6M 0.5% 24
2026
Q1
$122M Buy
92,196
+6,107
+7% +$8.37M 0.54% 29
2025
Q4
$92.1M Sell
86,089
-4,111
-5% -$4.29M 0.34% 48
2025
Q3
$87.3M Buy
90,200
+78,789
+690% +$61.9M 0.34% 56
2025
Q2
$9.14M Sell
11,411
-25,612
-69% -$18.4M 0.04% 266
2025
Q1
$24.5M Buy
37,023
+22,914
+162% +$16.7M 0.11% 155
2024
Q4
$9.78M Sell
14,109
-2,517
-15% -$1.81M 0.04% 262
2024
Q3
$13.9M Buy
+16,626
New +$14.9M 0.08% 211

Other funds holding ASML

Bridgewater Associates's ASML Position: Q2 2026 in Review

Bridgewater Associates reduced its ASML (ASML) stake by 33% in Q2 2026, selling an estimated $48.6M and leaving 61,675 shares worth $123M. The position accounts for 0.5% of the portfolio, ranked #24.

Bridgewater Associates first reported a position in ASML in Q3 2024 and has held it in 8 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Bridgewater Associates held 61,675 shares of ASML worth $123M as of Q2 2026.
  • Bridgewater Associates sold 30,521 ASML shares in Q2 2026, an estimated $48.6M.
  • ASML made up 0.5% of Bridgewater Associates's portfolio in Q2 2026, its #24 holding.
  • Bridgewater Associates first reported a position in ASML in Q3 2024 and has held it in 8 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.